Mutasem Taha

Dikutip oleh

	Semua	Sejak 2020
Kutipan	5568	2599
indeks-h	41	22
indeks-i10	133	78

580

290

145

435

2006200720082009201020112012201320142015201620172018201920202021202220232024202525 39 97 80 116 184 228 233 247 264 412 326 261 334 372 466 552 569 516 119

Akses publik

Lihat semua

13 artikel

4 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Yasser BustanjiProfessor of Biochemistry and Clinical Chemistry, The University of JordanEmail yang diverifikasi di ju.edu.jo
Mahmoud Al-Sha'erZarqa University-Faculty of PharmacyEmail yang diverifikasi di zu.edu.jo
Ma'mon M. Hatmal مأمون حتملVisiting Professor Stanford, Professor of Biochemistry and Molecular Biology Hashemite UniversityEmail yang diverifikasi di hu.edu.jo
Khaled AiedehProfessor of PharmaceuticsEmail yang diverifikasi di ju.edu.jo
Mohammad MohammadFaculty of Pharmacy, The University of JordanEmail yang diverifikasi di ju.edu.jo
Mohammad A KhanfarAlfaisal University - University of JordanEmail yang diverifikasi di ju.edu.jo
Malek ZihlifDepartment of Pharmacology, Faculty of Medicine, University of JordanEmail yang diverifikasi di ju.edu.jo
Maha HabashAqaba University of TechnologyEmail yang diverifikasi di aut.edu.jo
Isra DmourThe Hashemite University, Faculty of Pharmaceutical SciencesEmail yang diverifikasi di staff.hu.edu.jo
Amal G. Al-BakriProfessor of Pharmaceutical Microbiology, Faculty of Pharmacy, The University of JordanEmail yang diverifikasi di ju.edu.jo
Hiba ZalloumHamdi Mango Center for Scientific Research, The University of JordanEmail yang diverifikasi di ju.edu.jo
Mohamed GhusseinAssistant Professor of Biochemistry, Al Azhar University-GazaEmail yang diverifikasi di alazhar.edu.ps
Hatim S. AlKhatibSchool of Pharmacy, University of JordanEmail yang diverifikasi di ju.edu.jo
Reema Abu KhalafAl-Zaytoonah University of JordanEmail yang diverifikasi di zuj.edu.jo
Afaf H. AL-NadafMutah university ProfessorEmail yang diverifikasi di mutah.edu.jo
Safa DaoudAssociate Professor, Faculty of Pharmacy, Applied Science Private UniversityEmail yang diverifikasi di asu.edu.jo
Ahmad DisiProfessor , The University Of JordanEmail yang diverifikasi di ju.edu.jo
Samer R. AbulateefehThe University of JordanEmail yang diverifikasi di ju.edu.jo
Lina A. DahabiyehProfessor of Bioanalysis and Biomarker Discovery, The University of JordanEmail yang diverifikasi di ju.edu.jo
Walhan ALSHAERAssociate Professor, Al-Ahliyya Amman University and University of JordanEmail yang diverifikasi di ammanu.edu.jo

Ikuti

Mutasem Taha

Professor of Drug Design, University of Jordan

Email yang diverifikasi di ju.edu.jo - Beranda

Pharmaceutics Computer-Aided Molecular Design Medicinal Chemistry


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Degradability of chitosan micro/nanoparticles for pulmonary drug delivery N Islam, I Dmour, MO Taha Heliyon 5, e01684, 2019	248	2019
Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine I Al-masri, KM Mohammad, MO Taha journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009	231	2009
Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2 MM Hatmal, W Alshaer, MAI Al-Hatamleh, M Hatmal, O Smadi, MO Taha, ... Cells 9 (12), 2638, 2020	210	2020
Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon‐specific drug delivery systems K Aiedeh, MO Taha Archiv der pharmazie: an international journal pharmaceutical and medicinal …, 1999	180	1999
Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral … K Aiedeh, MO Taha European Journal of Pharmaceutical Sciences 13 (2), 159-168, 2001	134	2001
Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles … R Saeed, I Dmour, M Taha Frontiers in Bioengineering and Biotechnology, 2020	126	2020
Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for … MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ... Journal of medicinal chemistry 51 (7), 2062-2077, 2008	121	2008
Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ... Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009	115	2009
Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis MA Abbas, MO Taha, AM Disi, M Shomaf European journal of pharmacology 715 (1-3), 72-75, 2013	114	2013
Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ... Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007	109	2007
Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: Switching from enteric coating release into biphasic profiles MO Taha, W Nasser, A Ardakani, HS AlKhatib International Journal of Pharmaceutics 350 (1-2), 291-300, 2008	90	2008
Enhanced drug encapsulation and extended release profiles of calcium–alginate nanoparticles by using tannic acid as a bridging cross-linking agent SR Abulateefeh, MO Taha Journal of microencapsulation 32 (1), 96-105, 2015	88	2015
Investigation of the active constituents of Portulaca oleraceae L.(Portulacaceae) growing in Jordan AN Rasheed, FU Afifi, M Shaedah, MO Taha Pakistan Journal of Pharmaceutical Sciences 17 (1), 37-45, 2004	87	2004
Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies MO Taha, M Habash, Z Al-Hadidi, A Al-Bakri, K Younis, S Sisan Journal of chemical information and modeling 51 (3), 647-669, 2011	86	2011
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening IM Al‐masri, MK Mohammad, MO Taha ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008	82	2008
Combining ligand-based pharmacophore modeling, quantitative structure− activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive … MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh Journal of medicinal chemistry 51 (20), 6478-6494, 2008	82	2008
Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads A Al-Nadaf, GA Sheikha, MO Taha Bioorganic & medicinal chemistry 18 (9), 3088-3115, 2010	80	2010
Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening MO Taha, N Atallah, AG Al-Bakri, C Paradis-Bleau, H Zalloum, KS Younis, ... Bioorganic & medicinal chemistry 16 (3), 1218-1235, 2008	77	2008
Natural and semisynthetic polymers in pharmaceutical nanotechnology I Dmour, MO Taha Organic materials as smart nanocarriers for drug delivery, 35-100, 2018	76	2018
Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza … AM Abu Hammad, MO Taha Journal of chemical information and modeling 49 (4), 978-996, 2009	73	2009

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama